[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

CDTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.28%

Insider Buying (Last 12 Months): $109,700.00

Insider Selling (Last 12 Months): $60,087.02

Cidara Therapeutics Insider Trading History Chart

Cidara Therapeutics Share Price & Price History

^$0.69

▲ +0.01 (1.47%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Cidara Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2023	Leslie Tari	Insider	Sell	18,469	$0.95	$17,545.55	275,710
8/14/2023	Leslie Tari	Insider	Buy	10,000	$0.97	$9,700.00	294,179
8/8/2023	Jeffrey Stein	CEO	Buy	50,000	$0.96	$48,000.00	331,602
3/27/2023	Jeffrey Stein	CEO	Buy	50,000	$1.04	$52,000.00	281,602
3/13/2023	Leslie Tari	Insider	Sell	7,562	$1.53	$11,569.86	190,179
3/13/2023	Preetam Shah	CFO	Sell	6,648	$1.53	$10,171.44	148,141
3/13/2023	Shane Ward	COO	Sell	4,329	$1.53	$6,623.37	84,576
1/12/2023	Leslie Tari	Insider	Sell	11,814	$1.20	$14,176.80	1,484
9/19/2022	Preetam Shah	CFO	Sell	15,642	$0.77	$12,044.34	150,789
9/12/2022	Paul Daruwala	COO	Sell	16,199	$0.68	$11,015.32	221,099
9/12/2022	Taylor Sandison	Insider	Sell	18,478	$0.68	$12,565.04	291,753
3/21/2022	Brady Johnson	VP	Sell	654	$0.81	$529.74
3/11/2022	Brady Johnson	VP	Sell	945	$0.71	$670.95
1/5/2022	Brady Johnson	VP	Sell	416	$1.25	$520.00
1/5/2022	Leslie Tari	Insider	Sell	1,252	$1.25	$1,565.00
1/5/2022	Paul Daruwala	COO	Sell	5,133	$1.25	$6,416.25
11/12/2021	Jeffrey Stein	CEO	Buy	50,000	$1.59	$79,500.00
11/12/2021	Preetam Shah	CFO	Buy	20,000	$1.54	$30,800.00
9/13/2021	Timothy R. Franson	Director	Buy	7,000	$2.12	$14,840.00
8/18/2021	Jeffrey Stein	CEO	Buy	40,000	$1.72	$68,800.00
4/1/2021	Jessica Oien	General Counsel	Sell	1,177	$2.66	$3,130.82	6,141
4/1/2021	Neil Abdollahian	Insider	Sell	1,469	$2.66	$3,907.54	55,440
4/1/2021	Paul Daruwala	COO	Sell	593	$2.66	$1,577.38	49,724
1/5/2021	Jessica Oien	General Counsel	Sell	824	$2.06	$1,697.44	6,141
1/5/2021	Neil Abdollahian	Insider	Sell	2,868	$2.06	$5,908.08	55,440

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Cidara Therapeutics (NASDAQ:CDTX)

29.09% of Cidara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cidara Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Mercer Global Advisors Inc. ADV	28,750	$27K	0.0%	N/A	0.032%
11/15/2023	GSA Capital Partners LLP	136,974	$0.13M	0.0%	N/A	0.151%
11/14/2023	Schonfeld Strategic Advisors LLC	611,100	$0.58M	0.0%	-5.2%	0.676%
11/14/2023	Pale Fire Capital SE	54,356	$51K	0.0%	N/A	0.060%
11/13/2023	Invesco Ltd.	42,223	$40K	0.0%	+68.8%	0.047%
11/9/2023	Tocqueville Asset Management L.P.	98,000	$92K	0.0%	-13.3%	0.108%
10/24/2023	Raymond James Financial Services Advisors Inc.	79,119	$75K	0.0%	+25.2%	0.088%
10/17/2023	Flagship Harbor Advisors LLC	30,011	$28K	0.0%	N/A	0.033%
8/21/2023	Osaic Holdings Inc.	51,875	$59K	0.0%	+33.4%	0.057%
8/15/2023	XTX Topco Ltd	449,138	$0.51M	0.1%	+201.8%	0.498%
8/15/2023	Alethea Capital Management LLC	1,627,670	$1.84M	2.0%	-3.0%	1.804%
8/14/2023	Schonfeld Strategic Advisors LLC	644,900	$0.73M	0.0%	-3.2%	0.715%
8/14/2023	Marshall Wace LLP	89,315	$0.10M	0.0%	+216.0%	0.099%
8/14/2023	State Street Corp	254,037	$0.29M	0.0%	-7.7%	0.281%
8/11/2023	Renaissance Technologies LLC	1,549,573	$1.75M	0.0%	+23.3%	1.717%
8/11/2023	BlackRock Inc.	961,718	$1.09M	0.0%	+29.7%	1.066%
8/11/2023	Kestra Advisory Services LLC	76,500	$86K	0.0%	+192.7%	0.085%
8/11/2023	Geode Capital Management LLC	727,710	$0.82M	0.0%	+10.3%	0.806%
8/11/2023	Northern Trust Corp	127,965	$0.15M	0.0%	+14.3%	0.142%
8/10/2023	Osaic Holdings Inc.	51,875	$59K	0.0%	+33.4%	0.057%
8/4/2023	Legacy Wealth Asset Management LLC	30,000	$34K	0.0%	N/A	0.033%
8/3/2023	Mackenzie Financial Corp	22,566	$26K	0.0%	N/A	0.025%
7/24/2023	Vontobel Holding Ltd.	82,185	$93K	0.0%	+55.5%	0.091%
7/18/2023	Stratos Wealth Partners LTD.	36,489	$41K	0.0%	+247.9%	0.041%
5/16/2023	Susquehanna International Group LLP	104,501	$0.13M	0.0%	N/A	0.116%
5/16/2023	State Street Corp	275,237	$0.35M	0.0%	+19.2%	0.306%
5/16/2023	Geode Capital Management LLC	659,667	$0.84M	0.0%	+11.3%	0.733%
5/15/2023	Schonfeld Strategic Advisors LLC	666,400	$0.85M	0.0%	N/A	0.740%
5/15/2023	Two Sigma Advisers LP	63,600	$81K	0.0%	+146.5%	0.071%
5/15/2023	Two Sigma Investments LP	133,500	$0.17M	0.0%	N/A	0.148%
5/15/2023	XTX Topco Ltd	148,835	$0.19M	0.0%	N/A	0.165%
5/12/2023	Renaissance Technologies LLC	1,256,773	$1.60M	0.0%	+6.0%	1.396%
5/12/2023	BlackRock Inc.	741,713	$0.94M	0.0%	+459.9%	0.824%
5/12/2023	Prudential Financial Inc.	38,600	$49K	0.0%	-36.9%	0.043%
5/12/2023	Charles Schwab Investment Management Inc.	26,814	$34K	0.0%	N/A	0.030%
5/11/2023	Acadian Asset Management LLC	941,574	$1.19M	0.0%	-25.1%	1.046%
5/10/2023	Tocqueville Asset Management L.P.	167,000	$0.21M	0.0%	+22.8%	0.186%
5/9/2023	Bank of New York Mellon Corp	74,210	$94K	0.0%	N/A	0.082%
5/9/2023	Callan Capital LLC	323,554	$0.41M	0.0%	+18.3%	0.359%
5/5/2023	Monashee Investment Management LLC	369,099	$0.47M	0.1%	N/A	0.410%
4/28/2023	Jeppson Wealth Management LLC	137,060	$0.17M	0.1%	-14.7%	0.191%
4/12/2023	Vontobel Holding Ltd.	52,841	$67K	0.0%	N/A	0.074%
2/15/2023	Jane Street Group LLC	62,482	$47K	0.0%	N/A	0.087%
2/15/2023	Millennium Management LLC	689,917	$0.52M	0.0%	+724.1%	0.963%
2/15/2023	Money Concepts Capital Corp	55,000	$42K	0.0%	N/A	0.077%
2/15/2023	Nantahala Capital Management LLC	4,367,464	$3.30M	0.2%	-4.2%	6.098%
2/13/2023	Callan Capital LLC	273,554	$0.21M	0.0%	N/A	0.382%
2/13/2023	Renaissance Technologies LLC	1,185,373	$0.90M	0.0%	-8.3%	1.655%
2/13/2023	Geode Capital Management LLC	592,724	$0.45M	0.0%	+1.3%	0.828%
2/9/2023	Tocqueville Asset Management L.P.	136,000	$0.10M	0.0%	+30.8%	0.190%
2/8/2023	Raymond James Financial Services Advisors Inc.	73,655	$56K	0.0%	-16.9%	0.103%
1/27/2023	Jeppson Wealth Management LLC	160,610	$0.12M	0.1%	-7.8%	0.224%
11/15/2022	State Street Corp	230,937	$0.15M	0.0%	+31.0%	0.322%
11/15/2022	BlackRock Inc.	196,609	$0.12M	0.0%	-15.7%	0.275%
11/14/2022	Point72 Asset Management L.P.	3,868,006	$2.43M	0.0%	-7.9%	5.401%
11/14/2022	Renaissance Technologies LLC	1,293,273	$0.81M	0.0%	+11.8%	1.806%
11/10/2022	Nantahala Capital Management LLC	4,559,201	$2.92M	0.2%	-5.4%	6.366%
11/4/2022	Prudential Financial Inc.	54,000	$34K	0.0%	N/A	0.078%
11/1/2022	Monashee Investment Management LLC	369,099	$0.23M	0.1%	N/A	0.535%
8/15/2022	Nantahala Capital Management LLC	4,819,090	$2.36M	0.1%	-2.7%	6.979%
8/13/2022	Renaissance Technologies LLC	1,156,257	$0.57M	0.0%	-19.6%	1.675%
8/11/2022	Knott David M Jr	635,254	$0.31M	0.1%	+9.7%	0.920%
8/3/2022	Jeppson Wealth Management LLC	181,075	$88K	0.0%	+25.9%	0.262%
8/1/2022	US Bancorp DE	262,072	$0.13M	0.0%	N/A	0.380%
5/16/2022	State Street Corp	176,237	$0.15M	0.0%	+14.1%	0.255%
5/13/2022	Renaissance Technologies LLC	1,437,845	$1.20M	0.0%	+1.7%	2.082%
5/13/2022	Nantahala Capital Management LLC	4,954,882	$4.13M	0.2%	-6.0%	7.176%
5/12/2022	Monashee Investment Management LLC	369,099	$0.31M	0.1%	N/A	0.535%
5/12/2022	Acadian Asset Management LLC	1,099,299	$0.91M	0.0%	+23.6%	1.592%
4/27/2022	Jeppson Wealth Management LLC	143,850	$0.12M	0.1%	+30.2%	0.211%
2/15/2022	Stonepine Capital Management LLC	2,311,530	$2.94M	1.3%	+195.3%	3.466%
2/15/2022	Laurion Capital Management LP	198,635	$0.25M	0.0%	N/A	0.298%
2/14/2022	Point72 Asset Management L.P.	4,200,000	$5.33M	0.0%	N/A	6.298%
2/10/2022	Acadian Asset Management LLC	889,469	$1.13M	0.0%	+51.6%	1.334%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	88,097	$0.11M	0.0%	+64.9%	0.132%
2/8/2022	Raymond James Financial Services Advisors Inc.	75,035	$95K	0.0%	-16.0%	0.113%
2/7/2022	West Family Investments Inc.	368,910	$0.47M	0.1%	N/A	0.553%
1/19/2022	Jeppson Wealth Management LLC	110,525	$0.14M	0.1%	+83.9%	0.166%
11/17/2021	Jeppson Wealth Management LLC	60,100	$0.13M	0.1%	+15.4%	0.121%
11/17/2021	Altium Capital Management LP	1,275,000	$2.02M	0.4%	N/A	2.569%
11/16/2021	Squarepoint Ops LLC	87,419	$0.20M	0.0%	-26.2%	0.177%
11/16/2021	Two Sigma Advisers LP	468,594	$1.05M	0.0%	+1,054.3%	0.947%
11/16/2021	Two Sigma Investments LP	373,338	$0.84M	0.0%	+571.5%	0.754%
11/16/2021	BVF Inc. IL	4,776,904	$10.70M	0.4%	+9.9%	9.649%
11/15/2021	Marshall Wace LLP	184,027	$0.41M	0.0%	N/A	0.372%
11/12/2021	Renaissance Technologies LLC	1,120,261	$2.51M	0.0%	+7.1%	2.263%
11/12/2021	Stonepine Capital Management LLC	782,817	$1.75M	0.8%	-35.4%	1.581%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	53,431	$0.12M	0.0%	N/A	0.108%
11/10/2021	Goldman Sachs Group Inc.	109,894	$0.25M	0.0%	-17.2%	0.222%
11/9/2021	BlackRock Inc.	332,066	$0.74M	0.0%	-10.3%	0.671%
11/9/2021	Monashee Investment Management LLC	369,099	$0.83M	0.2%	N/A	0.746%
10/19/2021	Kestra Advisory Services LLC	30,500	$68K	0.0%	N/A	0.062%
9/3/2021	Parametric Portfolio Associates LLC	34,001	$69K	0.0%	N/A	0.069%
8/17/2021	Millennium Management LLC	580,793	$1.17M	0.0%	+810.8%	1.203%
8/17/2021	Bridgeway Capital Management LLC	118,878	$0.24M	0.0%	-27.5%	0.246%
8/17/2021	BVF Inc. IL	4,346,904	$8.78M	0.3%	+16.2%	9.002%
8/16/2021	Squarepoint Ops LLC	118,482	$0.24M	0.0%	-36.7%	0.245%
8/16/2021	Opaleye Management Inc.	73,351	$0.15M	0.0%	N/A	0.152%
8/16/2021	Alethea Capital Management LLC	1,172,044	$2.37M	1.5%	+0.7%	2.427%
8/16/2021	Charles Schwab Investment Management Inc.	25,006	$51K	0.0%	-66.7%	0.052%

Data available starting January 2016

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California.

Today's Range

Now: $0.69

$0.68

$0.71

50 Day Range

MA: $0.86

$0.68

$1.14

52 Week Range

Now: $0.69

$0.46

$2.10

Volume

252,796 shs

Average Volume

1,505,462 shs

Market Capitalization

$62.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Cidara Therapeutics?: Cidara Therapeutics' top insider investors include:
Jeffrey Stein (CEO)
Leslie Tari (Insider)
Taylor Sandison (Insider)
Paul Daruwala (COO)
Preetam Shah (CFO)
Shane Ward (COO)
Brady Johnson (VP)
Learn More about top insider investors at Cidara Therapeutics.
Who are the major institutional investors of Cidara Therapeutics?: Cidara Therapeutics' top institutional shareholders include:
Schonfeld Strategic Advisors LLC — 0.68%
GSA Capital Partners LLP — 0.15%
Tocqueville Asset Management L.P. — 0.11%
Raymond James Financial Services Advisors Inc. — 0.09%
Pale Fire Capital SE — 0.06%
Invesco Ltd. — 0.05%
Learn More about top institutional investors of Cidara Therapeutics stock.
Which institutional investors are selling Cidara Therapeutics stock?: During the previous quarter, CDTX stock was sold by these institutional investors:
Schonfeld Strategic Advisors LLC
Tocqueville Asset Management L.P.
In the last year, company insiders that have sold Cidara Therapeutics company stock include:
Jeffrey Stein (CEO)
Leslie Tari (Insider)
Taylor Sandison (Insider)
Learn More investors selling Cidara Therapeutics stock.
Which institutional investors are buying Cidara Therapeutics stock?: Within the last quarter, CDTX stock was bought by institutional investors including:
GSA Capital Partners LLP
Pale Fire Capital SE
Flagship Harbor Advisors LLC
Mercer Global Advisors Inc. ADV
Invesco Ltd.
Raymond James Financial Services Advisors Inc.
Within the last year, these company insiders have bought Cidara Therapeutics stock:
Jeffrey Stein (CEO)
Leslie Tari (Insider)
Learn More investors buying Cidara Therapeutics stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

CDTX Insider Trading

Cidara Therapeutics Insider Trading History Chart

Cidara Therapeutics Share Price & Price History

Cidara Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Cidara Therapeutics (NASDAQ:CDTX)

Institutional Buying and Selling by Quarter

Cidara Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Cidara Therapeutics?

Who are the major institutional investors of Cidara Therapeutics?

Which institutional investors are selling Cidara Therapeutics stock?

Which institutional investors are buying Cidara Therapeutics stock?